Prevalence of amyloid-β pathology in distinct variants of primary progressive aphasia

David Bergeron, Maria L. Gorno-Tempini, Gil D. Rabinovici, Miguel A. Santos-Santos, William Seeley, Bruce L. Miller, Yolande Pijnenburg, M. Antoinette Keulen, Colin Groot, Bart N. M. van Berckel, Wiesje M. van der Flier, Philip Scheltens (+74 others)
2018 Annals of Neurology  
To estimate the prevalence of amyloid positivity, defined by positron emission tomography (PET)/cerebrospinal fluid (CSF) biomarkers and/or neuropathological examination, in primary progressive aphasia (PPA) variants.
doi:10.1002/ana.25333 pmid:30255971 pmcid:PMC6354051 fatcat:7x3fos5xzzbc5fphv5aq4uavxm